Sagetis to Attend Biotech Showcase in San Francisco - 9th - 11th January 2017
Barcelona, December 2016 - Sagetis Biotech is pleased to announce that Sagetis’ Chief Scientific Officer, Salvador Borros and CEO Eduard Diviu, will be attending Biotech Showcase (co-located with the JP Morgan Healthcare Conference) in San Francisco, CA, USA from the 9th - 11th January 2017. If you wish to meet with us, please get in touch and we will arrange a meeting.
About Biotech Showcase
Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
Biotech Showcase is co-produced by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of providing high quality business support services to the biotechnology industry.
About Sagetis Biotech
Sagetis Biotech is devoted to developing an innovative gene delivery technology to overcome a fundamental engineering challenge in gene therapy: the development of safe and effective delivery vectors. Privately funded and based in Barcelona, Sagetis Biotech was founded in 2010 as a spin-off from GEMAT (Materials Engineering Group) at IQS.